Overview

A Safety/Efficacy Study of Alprostadil Liposomes for Injection to Treat Lower Extremity Arteriosclerosis Obliterans

Status:
Unknown status

Trial end date:
2017-12-01

Target enrollment:

Participant gender:

Summary

A phase II,randomized,double-blind,multi-doses,positive drug parallel controlled,multi-center clinical trial to evaluate initially the efficacy and safety of alprostadil liposomes for injection in the treatment of atherosclerotic occlusive disease of the lower extremities.

Phase:

Phase 2

Details

Lead Sponsor:

Guangzhou Yipinhong Pharmaceutical CO.,LTD

Treatments:

Alprostadil